Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

CJC-1295 Ipamorelin 5mg Peptide Quant Peptides

CJC-1295 no DAC 5mg (Mod GRF 1-29)

CJC-1295 no DAC, also known as Modified GRF, is a truncated peptide analogue of growth hormone-releasing hormone, or GHRH. It was first developed in the 1980s and has been studied for its potential role in growth hormone-related research pathways.

Research involving Modified GRF has explored its effects on muscle repair, muscle growth, wound healing, bone strength, fat metabolism, and overall metabolic function. Studies have also investigated its potential influence on blood sugar regulation and immune system activity.

Because CJC-1295 no DAC acts through GHRH-related pathways, it remains an area of interest in research focused on recovery, body composition, metabolic health, and tissue repair.

$129.00

Buy 3 and save 3%

$125.13 each

Buy 5 and save 6%

$121.26 each

Buy 10 and save 9%

$117.39 each

Popular Peptides

Peptide Blends

CJC-1295 no DAC 5mg (Mod GRF 1-29)

Cosmetic Peptides

Purchase Peptides

CJC-1295 No DAC 2mg Peptide — Modified GRF 1-29

Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Molecular formula: C152H252N44O42
Molar Mass: 3368.7
Synonyms: Mod GRF 1-29, CJC-1295 no DAC

All articles, product descriptions, and related information provided on this website are intended for informational and educational purposes only.

The products offered on this website are intended strictly for in-vitro research use only. In-vitro studies, meaning “in glass,” are conducted outside of the body in controlled laboratory settings. These products are not medicines, drugs, food, dietary supplements, or cosmetics, and they have not been approved by the FDA to diagnose, prevent, treat, cure, or mitigate any medical condition, ailment, or disease.

Any bodily introduction, administration, or use in humans or animals is strictly prohibited.

Storage Instructions:

Storage & Stability

Our peptides are produced using a specialized freeze-drying process known as lyophilization. This process removes moisture from the peptide while preserving its structure, helping maintain stability during storage and shipping.

Before reconstitution, lyophilized peptides are typically presented as a dry, white powder or cake inside the vial. In this form, they are generally more stable than liquid peptides and can better tolerate short-term temperature changes that may occur during transit.

Once received, peptides should be stored in a cool, dry place away from direct light. For short-term storage, refrigeration at approximately 4°C / 39°F is commonly recommended. For longer-term storage, keeping lyophilized peptides frozen may help preserve their stability over time.

After the peptide is reconstituted with bacteriostatic water, it should be stored in the refrigerator and protected from light. Reconstituted peptides are generally recommended for use within 30 days to help maintain quality and stability.

In simple terms:
Lyophilized peptides are designed to remain stable while dry, but once mixed, they should be kept cold and handled with care.